Boehringer Ingelheim allocates COVID relief fund to support underserved communities and patients in India
Boehringer Ingelheim is making available a Euro One Million COVID relief fund to support underserved communities and patients in India. Learn more here.
We want to create value in areas of unmet medical need and engage with communities and society to improve lives – for humans and animals. Find out more.
COVID-19 Q&A for people with chronic respiratory conditions
Here you can find a summary of COVID-19 advice for those with chronic respiratory conditions. Click here to read the questions and answers and learn more.
Millennials are now shaping pet markets and facing new issues in pet healthcare. Click here to read and learn more about this new generation of pet owners.
Colleagues across Canada are doing their part during the pandemic by supporting their community’s needs. Click here to find out and learn more information.
In 1885, Albert Boehringer purchased a small tartar factory in the Rhine-Hessian village of Nieder-Ingelheim. Click here to learn more about our history.